High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression

被引:96
|
作者
Roh, Michael H. [2 ]
Yassin, Yosuf [3 ]
Miron, Alexander [3 ]
Mehra, Karishma K. [1 ,4 ]
Mehrad, Mitra [1 ,4 ]
Monte, Nicolas M. [1 ,4 ]
Mutter, George L. [1 ,4 ]
Nucci, Marisa R. [1 ,4 ]
Ning, Geng [1 ,4 ]
Mckeon, Frank D. [5 ]
Hirsch, Michelle S. [1 ,4 ]
Wa, Xian [1 ,4 ,6 ]
Crum, Christopher P. [1 ,4 ]
机构
[1] Brigham & Womens Hosp, Dept Pathol, Div Womens & Perinatal Pathol, Boston, MA 02115 USA
[2] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA
[3] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA
[6] ASTAR, Inst Med Biol, Singapore, Singapore
关键词
ovarian cancer; p16(ink4); p53; PTEN; PAX2; tubal intraepithelial carcinoma; TUBAL INTRAEPITHELIAL CARCINOMA; PELVIC SEROUS CARCINOMA; MUTATIONS; CANCER; PATHWAYS; TUMORS; WOMEN;
D O I
10.1038/modpathol.2010.119
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
High-grade endometrioid and serous carcinomas of the ovary and fallopian tube are responsible for the majority of cancer deaths and comprise a spectrum that includes early or localized (tubal intraepithelial carcinoma) and advanced (invasive or metastatic) disease. We subdivided a series of these tumors into three groups, (1) classic serous, (2) mixed serous and endometrioid and (3) endometrioid carcinomas and determined: (1) the frequencies of coexisting tubal intraepithelial carcinoma, (2) frequency of a dominant ovarian mass suggesting an ovarian origin and (3) immuno-localization of WT-1, p53, PTEN, PAX2 and p16(ink4). All tumors were analyzed for p53 mutations. Thirty six, 25 and 8% of groups 1-3 were associated with tubal intraepithelial carcinoma (P = 0.09) and 34, 45 and 62% predominated in one ovary (P = 0.028), respectively. Differences in frequencies of diffuse p53 immunostaining (85-93%), WT-1 (70-98%) and p16(ink4) positivity (69-75%) were not significant for all groups. Greater than 95% reduction in PAX2 and PTEN occurred in 67-75 and 5-12%, respectively; however, PAX2 and PTEN staining intensity, when present, was often heterogeneous, highlighting different tumor populations. PAX2 and PTEN expression were markedly reduced or absent in 12 of 12 and 4 of 12 tubal intraepithelial carcinomas. In summary, high-grade mullerian carcinomas share identical frequencies of altered or reduced expression of p53, PTEN and PAX2, all of which can be appreciated in tubal intraepithelial carcinomas. Because only a subset of these tumors appears to arise in the fallopian tube, attention to expression of these biomarkers in the ovary and other mullerian sites might facilitate the identification of other carcinogenic pathways. PAX2 and PTEN, in addition to p53 and p16(ink4), comprise a potentially important gene combination in high-grade pelvic carcinogenesis. Modern Pathology (2010) 23, 1316-1324; doi:10.1038/modpathol.2010.119; published online 18 June 2010
引用
收藏
页码:1316 / 1324
页数:9
相关论文
共 50 条
  • [1] Letter to the editor regarding 'Roh MH, Lassin Y, Miron A et al. High-grade fimbrial-ovarian carcinomas are unified by p53, PTEN and PAX2 expression'
    Gilks, C. Blake
    Clarke, Blaise A.
    Han, Guangming
    Koebel, Martin
    Longacre, Teri
    McCluggage, W. Glenn
    Seidman, Jeff D.
    Shaw, Patricia
    Soslow, Robert A.
    MODERN PATHOLOGY, 2011, 24 (09) : 1281 - 1282
  • [2] PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas
    Tung, Celestine S.
    Mok, Samuel C.
    Tsang, Yvonne T. M.
    Zu, Zhifei
    Song, Huijuan
    Liu, Jinsong
    Deavers, Michael T.
    Malpica, Anais
    Wolf, Judith K.
    Lu, Karen H.
    Gershenson, David M.
    Wong, Kwong-Kwok
    MODERN PATHOLOGY, 2009, 22 (09) : 1243 - 1250
  • [3] The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
    Koebel, Martin
    Reuss, Alexander
    du Bois, Andreas
    Kommoss, Stefan
    Kommoss, Friedrich
    Gao, Dongxia
    Kalloger, Steve E.
    Huntsman, David G.
    Gilks, C. Blake
    JOURNAL OF PATHOLOGY, 2010, 222 (02) : 191 - 198
  • [4] UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
    Hardy, Laura R.
    Salvi, Amrita
    Burdette, Joanna E.
    CANCERS, 2018, 10 (08)
  • [5] PTEN and p53 expression in primary ovarian carcinomas: immunohistochemical study and discussion of pathogenetic mechanisms
    Gomes, CP
    Andrade, LALA
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 : 254 - 258
  • [6] Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers
    Bischof, Katharina
    Knappskog, Stian
    Hjelle, Sigrun M.
    Stefansson, Ingunn
    Woie, Kathrine
    Salvesen, Helga B.
    Gjertsen, Bjorn T.
    Bjorge, Line
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
    Ali, Abir Salwa
    Gronberg, Malin
    Federspiel, Birgitte
    Scoazec, Jean-Yves
    Hjortland, Geir Olav
    Gronbaek, Henning
    Ladekarl, Morten
    Langer, Seppo W.
    Welin, Staffan
    Vestermark, Lene Weber
    Arola, Johanna
    Osterlund, Pia
    Knigge, Ulrich
    Sorbye, Halfdan
    Grimelius, Lars
    Janson, Eva Tiensuu
    PLOS ONE, 2017, 12 (11):
  • [8] Immunohistochemical Expression of p53 Gene and Clinicopathological Assessment of Low-grade Serous Ovarian Cancer and High-grade Serous Ovarian Cancer: A Cohort Study
    Bazard, Geeta
    Vashist, Minakshi
    Singh, Sunita
    Rohilla, Gulshan
    Paliwal, Nidhi
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (12) : QC10 - QC14
  • [9] PAX8 and PAX2 Expression in Endocervical Adenocarcinoma In Situ and High-Grade Squamous Dysplasia
    Shukla, Abhishek
    Thomas, Dafydd
    Roh, Michael H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2013, 32 (01) : 116 - 121
  • [10] p53 alteration in morphologically normal/benign breast tissue in patients with triple-negative high-grade breast carcinomas: breast p53 signature?
    Wang, Xi
    Stolla, Moritz
    Ring, Brian Z.
    Yang, Qi
    Laughlin, Todd S.
    Rothberg, Paul G.
    Skinner, Kristin
    Hicks, David G.
    HUMAN PATHOLOGY, 2016, 55 : 196 - 201